DekaBank Deutsche Girozentrale Lowers Stock Position in AptarGroup, Inc. (NYSE:ATR)

DekaBank Deutsche Girozentrale lessened its holdings in shares of AptarGroup, Inc. (NYSE:ATR - Free Report) by 9.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,734 shares of the industrial products company's stock after selling 3,283 shares during the period. DekaBank Deutsche Girozentrale's holdings in AptarGroup were worth $5,039,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Blue Trust Inc. grew its position in shares of AptarGroup by 281.0% in the second quarter. Blue Trust Inc. now owns 240 shares of the industrial products company's stock valued at $35,000 after purchasing an additional 177 shares in the last quarter. UMB Bank n.a. increased its stake in shares of AptarGroup by 446.5% in the 3rd quarter. UMB Bank n.a. now owns 235 shares of the industrial products company's stock worth $38,000 after acquiring an additional 192 shares during the last quarter. Gradient Investments LLC purchased a new position in shares of AptarGroup during the 2nd quarter worth $40,000. Versant Capital Management Inc boosted its position in shares of AptarGroup by 4,983.3% during the 2nd quarter. Versant Capital Management Inc now owns 305 shares of the industrial products company's stock valued at $43,000 after acquiring an additional 299 shares during the last quarter. Finally, Adirondack Trust Co. grew its holdings in shares of AptarGroup by 25.0% in the second quarter. Adirondack Trust Co. now owns 500 shares of the industrial products company's stock valued at $70,000 after purchasing an additional 100 shares during the period. Institutional investors and hedge funds own 88.52% of the company's stock.

AptarGroup Trading Up 0.9 %

ATR traded up $1.59 during mid-day trading on Friday, hitting $169.50. 316,280 shares of the stock were exchanged, compared to its average volume of 293,402. The company has a market cap of $11.28 billion, a PE ratio of 33.72, a PEG ratio of 2.91 and a beta of 0.58. The company has a current ratio of 1.62, a quick ratio of 1.15 and a debt-to-equity ratio of 0.32. The firm's fifty day moving average is $158.56 and its two-hundred day moving average is $149.74. AptarGroup, Inc. has a 1-year low of $122.29 and a 1-year high of $171.41.

AptarGroup declared that its board has approved a share repurchase plan on Thursday, October 10th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the industrial products company to repurchase up to 4.7% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's board believes its stock is undervalued.

AptarGroup Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 14th. Shareholders of record on Thursday, October 24th will be given a $0.45 dividend. The ex-dividend date of this dividend is Thursday, October 24th. This represents a $1.80 annualized dividend and a yield of 1.06%. AptarGroup's dividend payout ratio is presently 36.14%.

Insiders Place Their Bets

In related news, CEO Stephan B. Tanda sold 30,000 shares of AptarGroup stock in a transaction on Monday, October 28th. The stock was sold at an average price of $169.60, for a total value of $5,088,000.00. Following the completion of the transaction, the chief executive officer now directly owns 174,118 shares in the company, valued at approximately $29,530,412.80. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CEO Stephan B. Tanda sold 30,000 shares of the business's stock in a transaction on Monday, October 28th. The shares were sold at an average price of $169.60, for a total transaction of $5,088,000.00. Following the completion of the transaction, the chief executive officer now owns 174,118 shares in the company, valued at approximately $29,530,412.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Xiangwei Gong sold 800 shares of the firm's stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $146.56, for a total value of $117,248.00. Following the completion of the sale, the insider now owns 20,174 shares in the company, valued at approximately $2,956,701.44. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 47,457 shares of company stock worth $7,680,110 over the last 90 days. Corporate insiders own 1.00% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the stock. Jefferies Financial Group upgraded shares of AptarGroup from a "hold" rating to a "buy" rating and boosted their target price for the company from $155.00 to $215.00 in a report on Monday, October 14th. Dbs Bank upgraded AptarGroup from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, October 16th. Wells Fargo & Company increased their price target on AptarGroup from $168.00 to $185.00 and gave the stock an "overweight" rating in a report on Tuesday, October 15th. Finally, Robert W. Baird upped their target price on shares of AptarGroup from $170.00 to $185.00 and gave the company an "outperform" rating in a research report on Monday. Four research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $195.00.

AptarGroup Company Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.